<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37580814</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1546-0096</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>14</Day></PubDate></JournalIssue><Title>Pediatric rheumatology online journal</Title><ISOAbbreviation>Pediatr Rheumatol Online J</ISOAbbreviation></Journal><ArticleTitle>A novel PRKDC mutation caused B lymphocytes V(D)J rearrangement disorder in the SLE-DAH like symptoms patient.</ArticleTitle><Pagination><StartPage>84</StartPage><MedlinePgn>84</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">84</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12969-023-00840-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Analyzed the clinical features and treatment process of the patient suffering from immunodeficiency with systemic lupus erythematosus(SLE)-like syndrome in a novel mutation of PRKDC.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">The patient had multiple positive auto-antibodies, chest CT and bronchoscopy showed Diffuse alveolar hemorrhage(DAH), and psychiatric symptoms showed brain atrophy by magnetic resonance imaging (MRI). Whole exon sequencing showed that novel complex heterozygous mutations of PRKDC gene (C. 1777&#x2009;-&#x2009;710_1777-709INSA (IVS16/IC16), C.1337T&#x2009;&gt;&#x2009;A(p.Phe446Tyr). The mature B cell (CD19&#x2009;+&#x2009;CD27&#x2009;+&#x2009;CD38 dimIgD IgM-) were absent. The treatment of high-dose methylprednisolone (MP) and cyclophosphamide(CTX) can quickly relieve the symptoms of the patient.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We described the case of an infant immunodeficiency with SLE like-syndrome, which may cause by PRKDC mutation, treated successfully with high-dose MP and CTX.</AbstractText><CopyrightInformation>&#xa9; 2023. BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hongwei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Rd, Guangzhou, 510120, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yawen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Rd, Guangzhou, 510120, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Biyun</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Rd, Guangzhou, 510120, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dehui</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Rd, Guangzhou, 510120, China. dehuicheng2022@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. dehuicheng2022@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021A1515220043</GrantID><Agency>Basic and applied basic research foundation of guangdong province enterprise mutual funds</Agency><Country/></Grant><Grant><GrantID>202102010343</GrantID><Agency>Zhongnanshan Medical Foundation of Guangdong Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pediatr Rheumatol Online J</MedlineTA><NlmUniqueID>101248897</NlmUniqueID><ISSNLinking>1546-0096</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051747">DNA-Activated Protein Kinase</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber><NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C497263">PRKDC protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051747" MajorTopicYN="N">DNA-Activated Protein Kinase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="Y">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008775" MajorTopicYN="N">Methylprednisolone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060152" MajorTopicYN="Y">V(D)J Recombination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Immunodeficiency</Keyword><Keyword MajorTopicYN="N">Mutation</Keyword><Keyword MajorTopicYN="N">PRKDC</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>15</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37580814</ArticleId><ArticleId IdType="pmc">PMC10424403</ArticleId><ArticleId IdType="doi">10.1186/s12969-023-00840-9</ArticleId><ArticleId IdType="pii">10.1186/s12969-023-00840-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu CH, Chen CA, Lin SH, et al. Increased risk of early-onset childhood systemic lupus erythematosus for children born to affected parents: a nationwide child-parent cohort study[J] Front Immunol. 2022;13:966809. doi: 10.3389/fimmu.2022.966809.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.966809</ArticleId><ArticleId IdType="pmc">PMC9483159</ArticleId><ArticleId IdType="pubmed">36131920</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotstein GI, Pinto NF, Lobo A, et al. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study[J] Lupus. 2020;29(8):934&#x2013;42. doi: 10.1177/0961203320928406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320928406</ArticleId><ArticleId IdType="pubmed">32501172</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy HG, Maynes EJ, Saxena A, et al. Utilization of extracorporeal life support for diffuse alveolar damage and diffuse alveolar hemorrhage: a systematic review[J] Artif Organs. 2021;45(6):559&#x2013;68. doi: 10.1111/aor.13861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aor.13861</ArticleId><ArticleId IdType="pubmed">33190331</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang M, Chen R, Zhao L, et al. Risk factors for mortality of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysis[J] Arthritis Res Ther. 2021;23(1):57. doi: 10.1186/s13075-021-02435-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-021-02435-9</ArticleId><ArticleId IdType="pmc">PMC7885396</ArticleId><ArticleId IdType="pubmed">33593433</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu T, Zhang G, Lin H, et al. Clinical characteristics and risk factors of diffuse alveolar hemorrhage in systemic Lupus Erythematosus: a systematic review and Meta-analysis based on Observational Studies[J] Clin Rev Allergy Immunol. 2020;59(3):295&#x2013;303. doi: 10.1007/s12016-019-08763-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-019-08763-8</ArticleId><ArticleId IdType="pubmed">31440948</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Adhoubi NK, Bystrom J. Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies[J] Lupus. 2020;29(4):355&#x2013;63. doi: 10.1177/0961203320903798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320903798</ArticleId><ArticleId IdType="pmc">PMC7436451</ArticleId><ArticleId IdType="pubmed">32036761</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey JP, Nobbs M, McGettigan P, et al. Recessive mutations in MCM4/PRKDC cause a novel syndrome involving a primary immunodeficiency and a disorder of DNA repair[J] J Med Genet. 2012;49(4):242&#x2013;5. doi: 10.1136/jmedgenet-2012-100803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2012-100803</ArticleId><ArticleId IdType="pubmed">22499342</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurosawa A. Autophosphorylation and Self-Activation of DNA-Dependent protein Kinase[J]. Genes (Basel), 2021,12(7).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8305690</ArticleId><ArticleId IdType="pubmed">34356107</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu AL, Verronese E, Rice GI, et al. PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity[J] J Allergy Clin Immunol. 2015;135(6):1578&#x2013;88. doi: 10.1016/j.jaci.2015.01.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2015.01.040</ArticleId><ArticleId IdType="pmc">PMC4487867</ArticleId><ArticleId IdType="pubmed">25842288</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowan MJ, Gennery AR. Radiation-sensitive severe combined immunodeficiency: the arguments for and against conditioning before hematopoietic cell transplantation&#x2013;what to do?[J] J Allergy Clin Immunol. 2015;136(5):1178&#x2013;85. doi: 10.1016/j.jaci.2015.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2015.04.027</ArticleId><ArticleId IdType="pmc">PMC4641002</ArticleId><ArticleId IdType="pubmed">26055221</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobaleda C, Jochum W, Busslinger M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors[J] Nature. 2007;449(7161):473&#x2013;7. doi: 10.1038/nature06159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06159</ArticleId><ArticleId IdType="pubmed">17851532</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul-Razak HH, Rocca CJ, Howe SJ, et al. Molecular evidence of genome editing in a mouse model of Immunodeficiency[J] Sci Rep. 2018;8(1):8214. doi: 10.1038/s41598-018-26439-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-26439-9</ArticleId><ArticleId IdType="pmc">PMC5974076</ArticleId><ArticleId IdType="pubmed">29844458</ArticleId></ArticleIdList></Reference><Reference><Citation>Spielmann L, Nespola B, Severac F, et al. Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes[J] Ann Rheum Dis. 2019;78(8):1101&#x2013;6. doi: 10.1136/annrheumdis-2018-214439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214439</ArticleId><ArticleId IdType="pubmed">31126956</ArticleId></ArticleIdList></Reference><Reference><Citation>Adarsh MB, Kavadichanda CG, Shah S, et al. Anti Ku antibody is associated with haematological manifestations but not with overlap features in systemic lupus erythematosus[J] Clin Exp Rheumatol. 2021;39(Suppl 128):3&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">33200735</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek J, Groenwold RH, van der Burg M, et al. TREC based newborn screening for severe combined immunodeficiency disease: a systematic Review[J] J Clin Immunol. 2015;35(4):416&#x2013;30. doi: 10.1007/s10875-015-0152-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-015-0152-6</ArticleId><ArticleId IdType="pmc">PMC4438204</ArticleId><ArticleId IdType="pubmed">25893636</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>